FDA Drug Application (201407) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number201407
Product Number001
FormCAPSULE;ORAL
Dosage25MG;37.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE



Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.